Stock AKBA AKEBIA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Akebia Therapeutics, Inc.

Equities

AKBA

US00972D1054

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-21 pm EDT 		5-day change 1st Jan Change
1.13 USD -1.74% Intraday chart for Akebia Therapeutics, Inc. -8.13% -8.87%
May. 09 Transcript : Akebia Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024
May. 09 Earnings Flash (AKBA) AKEBIA THERAPEUTICS Reports Q1 Revenue $32.6M MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
AKEBIA THERAPEUTICS, INC. Stock Akebia Therapeutics, Inc.
 237M - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 114B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 107B
BIONTECH SE Stock BioNTech SE
 22.22B -
ARGENX SE Stock argenx SE
 21.28B -
BEIGENE, LTD. Stock BeiGene, Ltd.
 17.51B -
  1. Stock Market
  2. Equities
  3. AKBA Stock
  4. Charts Akebia Therapeutics, Inc.
  5. Sector Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW